Literature DB >> 7252793

Symbols in pharmacokinetics.

M Rowland, G Tucker.   

Abstract

To encourage uniformity in the presentation of pharmacokinetic data, a general nomenclature has been developed. The system has wide application. Flexibility is achieved through the use of general variables, constants, qualifying terms, and subscripts. Yet, through the use of implied terms, the symbols describing many common variables and constants are simple.

Mesh:

Substances:

Year:  1980        PMID: 7252793     DOI: 10.1007/bf01059548

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  2 in total

1.  STANDARDIZATION of definitions and symbols in respiratory physiology.

Authors: 
Journal:  Fed Proc       Date:  1950-09

2.  Symbols for compartmental models.

Authors: 
Journal:  Br J Anaesth       Date:  1979-09       Impact factor: 9.166

  2 in total
  25 in total

1.  Pharmacokinetic determinants in the design and evaluation of sustained-release dosage forms.

Authors:  H Boxenbaum
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

Review 2.  Current models in pharmacokinetics: applications in veterinary pharmacology.

Authors:  L D Kinabo; Q A McKellar
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

3.  A new method for assessment of drug disposition in muscle: application of statistical moment theory to local perfusion systems.

Authors:  T Kakutani; K Yamaoka; M Hashida; H Sezaki
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

4.  Comparative pharmacokinetics of benzodiazepines in dog and man.

Authors:  H Boxenbaum
Journal:  J Pharmacokinet Biopharm       Date:  1982-08

5.  Primary, secondary, and tertiary metabolite kinetics.

Authors:  M V St-Pierre; X Xu; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

6.  Standardization of symbols in clinical pharmacology.

Authors:  J K Aronson; H J Dengler; L Dettli; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Terminal half-life.

Authors:  A Rescigno; E Rocca
Journal:  J Pharmacokinet Biopharm       Date:  1993-02

8.  Pharmacokinetics of estramustine phosphate (Estracyt) in prostatic cancer patients.

Authors:  P O Gunnarsson; S B Andersson; S A Johansson; T Nilsson; G Plym-Forshell
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Pharmacokinetics of michellamine B, a naphthylisoquinoline alkaloid with in vitro activity against human immunodeficiency virus types 1 and 2, in the mouse and dog.

Authors:  J G Supko; L Malspeis
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

10.  Pharmacokinetic parameters for thallium (I)-ions in man.

Authors:  A Talas; D P Pretschner; H H Wellhöner
Journal:  Arch Toxicol       Date:  1983-05       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.